Titan Medical Inc.(Us) (TSE:TMD) has released an update.
Titan Medical Inc. has announced a definitive merger with Conavi Medical Inc. in an all-stock transaction aimed at creating a commercial-stage leader in hybrid intravascular imaging. The merger will see Titan acquiring all shares of Conavi, with the aim to commercialize Conavi’s Novasight Hybrid System, which offers advanced imaging to guide minimally invasive coronary procedures. The transaction is set to finalize around July 15, 2024, with plans for Titan’s common shares to transition from the Toronto Stock Exchange to the TSX Venture Exchange.
For further insights into TSE:TMD stock, check out TipRanks’ Stock Analysis page.
